Free Trial

Flossbach Von Storch SE Purchases 70,928 Shares of Procter & Gamble Company (The) $PG

Procter & Gamble logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Flossbach Von Storch SE bought 70,928 shares, raising its position to 3,167,654 shares (about 0.14% of P&G) valued at roughly $453.96 million, making P&G its 20th largest holding and ~1.8% of the firm's portfolio.
  • Recent results: P&G beat EPS ($1.59 vs. $1.56), reported $21.24B in revenue (up ~7.4% YoY), reaffirmed FY‑2026 guidance (EPS 6.83–7.09) and raised the quarterly dividend to $1.0885 ($4.35 annual, ~2.9% yield).
  • Ownership and sentiment: Insiders have been net sellers (252,715 shares worth about $41M over the last three months) while institutional ownership is ~65.8% and analysts hold a "Moderate Buy" consensus with a $161.06 average price target.
  • MarketBeat previews the top five stocks to own by May 1st.

Flossbach Von Storch SE grew its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 2.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,167,654 shares of the company's stock after purchasing an additional 70,928 shares during the quarter. Procter & Gamble makes up about 1.8% of Flossbach Von Storch SE's investment portfolio, making the stock its 20th largest holding. Flossbach Von Storch SE owned approximately 0.14% of Procter & Gamble worth $453,956,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. increased its stake in Procter & Gamble by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 237,459,756 shares of the company's stock worth $34,030,358,000 after buying an additional 2,829,151 shares in the last quarter. Assenagon Asset Management S.A. lifted its position in shares of Procter & Gamble by 100.8% in the fourth quarter. Assenagon Asset Management S.A. now owns 5,460,939 shares of the company's stock valued at $782,607,000 after acquiring an additional 2,741,924 shares in the last quarter. Amundi boosted its stake in shares of Procter & Gamble by 26.3% in the third quarter. Amundi now owns 10,682,455 shares of the company's stock worth $1,606,748,000 after acquiring an additional 2,222,560 shares during the period. Franklin Resources Inc. boosted its stake in shares of Procter & Gamble by 8.3% in the third quarter. Franklin Resources Inc. now owns 22,850,345 shares of the company's stock worth $3,510,955,000 after acquiring an additional 1,752,481 shares during the period. Finally, Danske Bank A S purchased a new stake in shares of Procter & Gamble during the third quarter worth about $252,853,000. 65.77% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Ma. Fatima Francisco sold 5,549 shares of the stock in a transaction on Friday, February 27th. The stock was sold at an average price of $165.29, for a total transaction of $917,194.21. Following the sale, the chief executive officer owned 1,029 shares in the company, valued at approximately $170,083.41. This represents a 84.36% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Chairman Jon R. Moeller sold 162,232 shares of Procter & Gamble stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the transaction, the chairman directly owned 319,385 shares of the company's stock, valued at $51,884,093.25. The trade was a 33.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 252,715 shares of company stock worth $40,966,904. 0.20% of the stock is currently owned by company insiders.

Procter & Gamble Price Performance

PG stock opened at $148.43 on Tuesday. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $170.99. The firm has a market capitalization of $344.95 billion, a P/E ratio of 21.70, a price-to-earnings-growth ratio of 5.72 and a beta of 0.41. The company has a fifty day simple moving average of $150.08 and a two-hundred day simple moving average of $148.64. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.44.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 31.88%. The firm had revenue of $21.24 billion for the quarter, compared to analysts' expectations of $21.52 billion. During the same period in the prior year, the company earned $1.54 EPS. The business's revenue was up 7.4% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Analysts anticipate that Procter & Gamble Company will post 6.95 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 24th will be given a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a yield of 2.9%. This is a boost from Procter & Gamble's previous quarterly dividend of $1.06. The ex-dividend date is Friday, April 24th. Procter & Gamble's dividend payout ratio (DPR) is currently 63.60%.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

Analysts Set New Price Targets

PG has been the topic of a number of research analyst reports. Rothschild & Co Redburn lowered their price target on Procter & Gamble from $157.00 to $155.00 and set a "neutral" rating on the stock in a report on Monday. Jefferies Financial Group lowered their target price on shares of Procter & Gamble from $179.00 to $175.00 and set a "buy" rating on the stock in a report on Monday, April 20th. Dbs Bank raised shares of Procter & Gamble from a "hold" rating to a "buy" rating in a research note on Friday, January 23rd. Morgan Stanley decreased their price target on shares of Procter & Gamble from $175.00 to $166.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 22nd. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Procter & Gamble in a report on Friday, March 27th. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $161.06.

Check Out Our Latest Stock Report on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines